2a Biosciences

2A Biosciences is pioneering a new class of disease-modifying therapies by unlocking the regenerative and neuroprotective power of serotonin 2A receptors. Our proprietary small molecules are designed to precisely activate 5-HT2A receptors to drive reinnervation, neuroprotection, and inflammation resolution across neurodegenerative ocular and CNS diseases. By targeting upstream biology that governs mitochondrial dysfunction, oxidative stress, and neuroinflammation, our approach simultaneously engages multiple degenerative pathways to halt disease progression at the root while promoting neuronal growth and functional repair.